Samrat Pharmachem Ltd. Live Share Price Today, Share Analysis and Chart

Name: Samrat Pharmachem Ltd.: Is Infosys Ltd. worth buying?
Item: Samrat Pharmachem Ltd.
Rating: 2.871583375
Author: Trendlyne DVM scores

Mid-range Performer

about

Samrat Pharmachem principal activities are manufacturing and selling chemicals.

324.95 6.95 (2.19%)

49.70% Fall from 52W High

332

BSE Volume

BSE 29 Aug, 2025 3:31 PM (IST)

Dividend

Samrat Pharmachem Ltd. has an upcoming dividend of ₹1.00 per share due on 18 Sep 2025 See details

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

70.0 / 100

Mid Valuation

48.7 / 100

Technically Neutral

41.1 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

No estimates available

Samrat Pharmachem Live Price Chart

Loading Fundamental data..

Loading data..

Is Samrat Pharmachem Ltd. worth buying?

47 Votes:

Buy 68.09%

Sell 12.77%

Hold 19.15%

Samrat Pharmachem Ltd. Live Share Price Today, Share Analysis and Chart

Samrat Pharmachem principal activities are manufacturing and selling chemicals.

49.70% Fall from 52W High

SWOT Analysis

Samrat Pharmachem Live Price Chart